The annual list is intended to honor inventions that make the world a better and smarter place.
Galway, Ireland, October 15th / PRNewswire / -- Medtronic plc ( NYSE : MDT ) Today, it was announced that the Stealth AXiS ™ surgical system and the Corsano ™* multi-parameter wearable device have been selected for TIME's list of Best Inventions of 2026.
This annual award is selected and judged by TIME, with the aim of highlighting the most influential new products and new concepts of the year. This dual recognition highlights Medtronic's commitment at the corporate level to drive healthcare transformation, that is, to help clinicians make more informed decisions through connected technologies and to improve the delivery of healthcare services.
Advancing connected surgery through Stealth AXiS ™
Stealth AXiS ™ The surgical system has gained recognition for integrating planning, navigation, and robot-assisted execution into a single platform, which is specifically designed for complex surgeries. This system addresses a challenge encountered during surgeries: the technologies used for planning, imaging, navigation, and execution are often scattered across multiple systems.
Stealth AXiS ™ system is built within Medtronic's AiBLE ™ intelligent ecosystem, and it can support surgeries for the spine, cranium, and ear, nose, and throat ( ENT ). It integrates real-time data, advanced imaging, and capabilities based on AI into the surgical process, thereby creating a more interconnected approach to care throughout the entire surgical procedure.
The President of the Cranial and Spinal Technology Operations Unit under Medtronic's Neurosciences Business Portfolio, Michael Carter, stated: "Being recognized as the TIME Best Invention is a meaningful acknowledgment of the innovation behind the Stealth AXiS ™ system and our commitment to advancing the connected surgery ecosystem. Our goal is to help surgical teams achieve greater connectivity and intelligence by integrating planning, navigation, and robotics technologies into one platform."
Leveraging Corsano ™* multi-parameter wearable devices to extend continuous patient monitoring
Corsano ™*Multi-parameter wearable devices have gained recognition for their ability to extend clinical visibility beyond traditional bedside monitoring through a lightweight, cordless wearable device. These devices are designed to capture key vital signs and trend information to assist in clinical decision-making. Manufactured by Corsano Health B .V., they are distributed in the United States and Western Europe by Medtronic, allowing clinicians to access patient data nearly in real-time, covering both hospital and home settings.
A single point test may leave patients in an unmonitored state for 96% of the time. However, this medical-grade wearable device can monitor heart rate, blood oxygen saturation ( SpO 2 ), respiratory rate, skin temperature, and activity levels, helping clinicians obtain patient information in a timely manner, while also enhancing the patient's freedom of movement and comfort.
Kate Benedict, President of Medtronic's Acute Care and Monitoring Business Unit, stated: "Being selected for the TIME Best Invention list demonstrates the possibilities that next-generation patient monitoring technology can achieve. The Corsano™* multi-parameter wearable device significantly expands our portfolio of wearable patient monitoring products and also reflects our commitment to helping clinicians stay connected to patient data wherever care is provided, thereby enabling them to make more informed decisions based on patient insights."
About Medtronic
Think boldly, act even more boldly. We are Medtronic. Medtronic, headquartered in Galway, Ireland, is a globally leading medical technology company dedicated to finding and providing solutions to address the most challenging health issues facing humanity. The company's mission—to alleviate suffering, restore health, and extend life—unites over 95,000 passionate employees in more than 150 countries. Our technologies and therapies cover 70 health conditions, including cardiac devices, surgical robots, surgical tools, patient monitoring systems, and more. With our diverse expertise, strong curiosity, and a desire to help everyone in need, we provide innovative technologies every second, every hour, every day, transforming the lives of two people. We give back to the world with insight-driven care, patient-centered experiences, and better outcomes. Everything we do is aimed at creating something extraordinary. For more information, please visit www.Medtronic.com, and follow us at LinkedIn.
Regarding Medtronic Cranial and Spinal Technology Business
As global market leaders, Medtronic Cranial, and, and Spinal Technologies are transforming the standards of care in spinal and cranial surgery by putting patients first and addressing the complex challenges faced by spinal surgeons and neurosurgeons. With a product portfolio of 150 products covering over 20 different pathologies, they serve more than 4 million patients annually. Building on a tradition of innovation, the AiBLE™ ecosystem combines advanced technology, data, and a patient-centered approach to provide customized solutions that enhance surgical precision, improve workflow efficiency, and strive for better outcomes before, during, and after surgery.
About acute care and monitoring
At Medtronic Acute Care & Monitoring, we put patients first by designing patient monitoring and airway management technologies to support critical-care nursing. By simplifying clinical decision-making, work processes, and operational performance, we help nursing teams focus on patients, while also enabling institutions to create sustainable value from their technological investments. Our vision is to make personalized patient care possible anytime, anywhere. For more information, please visit medtronic.com / ACM.
About Medtronic Otorhinolaryngology Services
The otolaryngology (ENT) business of Medtronic is a market leader in the global ENT field, providing innovative technology to nearly 3 million patients each year. For over 25 years, we have been collaborating with doctors to drive the development of specialized care in this area. Our product portfolio supports surgeries related to chronic sinusitis and head and neck cancer, covering surgical navigation, tissue health, powered instruments, local drug delivery, intraoperative nerve monitoring, and parathyroid gland detection. Since the introduction of the LandmarX™ image-guided surgery system in 1998, we have been a global leader in the field of navigation and continue to advance this industry through new generations of platforms, including Stealth AXiS™ and Surgical System. For more information, please visit Medtronic.com / AXiSENT.
About Corsano Health
Corsano Health B.V. is a leading medical technology company that develops, manufactures, and sells advanced real-time remote patient monitoring solutions. With the CE-MDR medical certification system and FDA licensing, the Corsano™ multi-parameter wearable devices are setting new standards for continuous monitoring, focusing on reducing medical costs and supporting clinical teams in improving outcomes and patient experiences. For more information, please visit https:// corsano.com.
* Corsano ™* Multi-parameter wearable devices are manufactured by Corsano Health B .V. and distributed by Medtronic. Corsano ™ Multi-parameter wearable devices should not be used as the sole basis for diagnosis or treatment, but rather as an auxiliary tool for patient assessment. This device is not suitable for high-risk care environments, nor is it suitable for patients with acute heart disease who may develop life-threatening arrhythmias, or for SpO2 monitoring under conditions of high exercise or low perfusion.
1 Curry and Jungquist : A critical assessment of monitoring practices, patient deterioration and alarm fatigue on inpatient wards : a review. Patient Safety in __BJWKEEP_00020 2014 8:29.
Any forward-looking statements are subject to risks and uncertainties, including those identified in Medtronic's periodic reports submitted to the U.S. Securities and Exchange Commission. Actual results may differ significantly from expected results.
